ctrl K

Watchlist Price Alert

Acer Therapeutics Inc. (ACER)

NASDAQ: ACER · Real-Time Price · USD

0.66

-0.14 (-17.96%)

At close: Nov 20, 2023, 8:59 PM

Acer Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	1.26M	n/a	n/a	432.12K	-246.3K	2.91M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	1.26M	n/a	n/a	432.12K	-246.3K	2.91M
Operating Income	-24.61M	-15.95M	-22.8M	-29.9M	-21.71M	-13.95M	-7.99M
Interest Income	1.82K	49.27	13.58K	471.27K	412.55K	14.85K	n/a
Pretax Income	-26.24M	-15.37M	-22.89M	-29.42M	-21.28M	-14.19M	-7.98M
Net Income	-27.86M	-14.73M	-22.9M	-28.88M	-21.28M	-14.19M	-7.98M
Selling & General & Admin	12.69M	10.7M	10.95M	16.05M	9.26M	5.22M	3.12M
Research & Development	11.92M	6.51M	11.85M	13.85M	12.45M	8.73M	6.5M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	10.63K
Operating Expenses	24.61M	17.21M	22.8M	29.9M	21.71M	13.95M	9.86M
Interest Expense	101.43K	n/a	n/a	n/a	987.00	245.06K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	24.61M	17.21M	22.8M	29.9M	21.71M	13.95M	9.86M
Income Tax Expense	1.62M	-645.31K	11.81K	-537.75K	-432.12K	246.3K	1.04M
Shares Outstanding (Basic)	15.77M	14.27M	11.12M	10.09M	8.56M	3.69M	680.67K
Shares Outstanding (Diluted)	15.77M	14.27M	11.12M	10.09M	8.56M	3.69M	680.67K
EPS (Basic)	-1.77	-1.03	-2.06	-2.86	-2.49	-3.84	-11.72
EPS (Diluted)	-1.77	-1.03	-2.06	-2.86	-2.49	-3.84	-11.72
EBITDA	-24.55M	-15.88M	-22.73M	-28.34M	-21.25M	-13.95M	-6.7M
EBIT	-26.14M	n/a	n/a	n/a	-21.28M	-13.95M	n/a
Depreciation & Amortization	-198.47K	-54.76K	96.2K	-8.21K	27.74K	4K	238.13K